Clinical Trial Update: Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC) [NA]

View source ↗

Summary

This entry reports the completion of a clinical trial evaluating M2ES with paclitaxel and carboplatin (the TC regimen) for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• M2ES
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Non Small Cell Lung Cancer | NA | Status: COMPLETED